Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psychiatric Impact of Cannabis Policy: More Than a Legal Framework
2
What's Next for Psychedelics in Psychiatry? COMP360 and Beyond
3
Oral Cannabinoid From MediPharm Shows Significant Reduction in Agitation in Alzheimer Disease and Dementia
4
Podcast: Managing Co-Occurring Mood and Substance Use Disorders With Michael J. Ostacher, MD, MPH
5